Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Emi Ishigami"'
Autor:
Shouko Hayama, Rikiya Nakamura, Takayuki Ishige, Takafumi Sangai, Masahiro Sakakibara, Hiroshi Fujimoto, Emi Ishigami, Takahito Masuda, Ayako Nakagawa, Ryotaro Teranaka, Satoshi Ota, Sakae Itoga, Naohito Yamamoto, Takeshi Nagashima, Masayuki Otsuka
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background There is pressing needs to find the biomarker in the selection of neoadjuvant therapy in postmenopausal luminal breast cancer patients. We examined the hypothesis that PIK3CA mutations and low phosphatase and tensin homolog (PTEN)
Externí odkaz:
https://doaj.org/article/0c7fbaaf8c9747b2b95b0b619b492bb5
Autor:
EMI ISHIGAMI1, MASAHIRO SAKAKIBARA1 sakaki@faculty.chiba-u.jp, JUNTA SAKAKIBARA1, TOSHIAKI IWASE1, SHOKO HAYAMA1, TAKAHITO MASUDA1, AYAKO NAKAGAWA1, TAKESHI NAGASHIMA1, TAKAFUMI SANGAI1, HIROSHI FUJIMOTO1, MASAYUKI OTSUKA1
Publikováno v:
Molecular & Clinical Oncology. 2017, Vol. 7 Issue 6, p1079-1082. 4p.
Autor:
Masahiro Sakakibara, Ayako Nakagawa, Takahito Masuda, Yukio Nakatani, Emi Ishigami, Junta Sakakibara, Takeshi Nagashima, Takafumi Sangai, Shouko Hayama, Hiroshi Fujimoto, Masayuki Otsuka
Publikováno v:
Breast Cancer. 26:180-189
Tumors can acquire tolerance to tumor immunity and develop enhanced proliferation. Regulatory B cells (Bregs), whose role in immune tolerance is similar to that of regulatory T cells (Tregs), appear to be involved in tumor immunity. Recently, Bregs w
Autor:
Masahiro Sakakibara, Shunsuke Tabe, Ayako Nakagawa, Takahito Masuda, Takeshi Nagashima, Emi Ishigami, Junta Sakakibara, Toshiaki Iwase, Shouko Hayama, Takafumi Sangai
Publikováno v:
Molecular and Clinical Oncology. 6:266-270
The aim of the present study was to evaluate the association between changes in the neutrophil-to-lymphocyte ratio and the survival rate, as well as tumor subtype, in recurrent breast cancer. Patients with recurrent breast cancer following surgery we
Autor:
Masahiro Sakakibara, Emi Ishigami, Takafumi Sangai, Toshiaki Iwase, Shouko Hayama, Junta Sakakibara, Takeshi Nagashima, Masaru Miyazaki, Takahito Masuda
Publikováno v:
Cancer Medicine
Obesity is known to decrease the efficacy of neoadjuvant chemotherapy (NAC) against breast cancer; however, the relationship between actual body composition and NAC outcomes remains unknown. Therefore, we determined the effect of body composition on
Autor:
Hiroshi Fujimoto, Ayako Nakagawa, Masahiro Sakakibara, Masayuki Otsuka, Emi Ishigami, Takahito Masuda, Shoko Hayama, Takafumi Sangai, Toshiaki Iwase, Takeshi Nagashima, Junta Sakakibara
Publikováno v:
Molecular and Clinical Oncology.
Neoadjuvant chemotherapy (NAC) with anthracyclines followed by taxane chemotherapy has become the standard treatment for patients with locally advanced, operable breast cancer. Recently, the efficacy of nanoparticle albumin-bound paclitaxel (nab-PTX)
Autor:
Shinichiro, Nakada, Jun, Kawamoto, Takuya, Yoichi, Kimio, Shinoda, Emi, Ishigami, Ryotaro, Teranaka, Masaru, Miyazaki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(12)
A 71-year-old man was admitted to our hospital because of abdominal pain. An upper gastrointestinal endoscopy revealed a type 3 tumor in the lesser curvature of the gastric body. A computed tomography (CT) scan showed synchronous liver metastasis in
Autor:
Takeshi, Nagashima, Masahiro, Sakakibara, Takafumi, Sangai, Junta, Sakakibara, Toshiaki, Iwase, Shoko, Hayama, Emi, Ishigami, Takahito, Masuda, Ayako, Nakagawa, Masaru, Miyazaki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(12)
Although radiofrequency ablation (RFA) is promising for the local treatment of breast cancer, data concerning the longterm results are limited. The present study attempted to evaluate the safety and efficacy of RFA and to clarify patient outcomes aft
Autor:
TOSHIAKI IWASE, TAKAFUMI SANGAI, MASAHIRO SAKAKIBARA, JUNTA SAKAKIBARA, EMI ISHIGAMI, SHOUKO HAYAMA, AYAKO NAKAGAWA, TAKAHITO MASUDA, SHUNSUKE TABE, TAKESHI NAGASHIMA
Publikováno v:
Molecular & Clinical Oncology; 2017, Vol. 6 Issue 2, p266-270, 5p